Cookies on our website

We use cookies on our website. To learn more about cookies, how we use them on our site and how to change your cookie settings please view our cookie policy.

Read more Close
Skip Ribbon Commands
Skip to main content
You searched for:
Search

Search

1-7 of 7 results
Results per page: 
Sort by: 
Allen & Overy has advised science-based pharmaceutical company Grünenthal on its acquisition of AstraZeneca’s European rights to prescription Nexium and the global (excluding the US and Japan) rights . Allen & Overy has advised science-based pharmaceutical company Grünenthal on its acquisition of
30 October 2018
http://www.allenovery.com/news/en-gb/articl … -with-AstraZeneca-for-Nexium-and-Vimovo.aspx
Our team regularly advises clients developing biotech products in areas including biotechnology derived proteins (such as insulin), immunologicals (such as vaccines and allergens), blood or plasma derived products, and engineered tissues.
09 April 2015
http://www.allenovery.com/expertise/sectors/life-sciences/Pages/Biotechnology.aspx
Allen & Overy is a global law firm with considerable expertise in the Pharmaceutical and Biotech sector. Our specialist lawyers have considerable experience advising well known pharma companies. Allen & Overy is a global law firm with considerable expertise in the Pharmaceutical and Biotech sector.
02 May 2012
http://www.allenovery.com/expertise/sectors/life-sciences/Pages/Pharmaceutical.aspx
HONG KONG – Allen & Overy said today that Glenmark Pharmaceuticals Limited’s USD170 million convertible bond with a rare “resettable onward starting equity-linked” feature, points to the revival of the Indian convertible bond market following reduced volumes in the last two years.
12 July 2016
http://www.allenovery.com/news/en-gb/articl … rtible-bond-market-using-rare-structure.aspx
Allen & Overy has advised the founders and shareholders of Walmark, Czech manufacturer of dietary supplements, OTC pharmaceuticals and other related products with subsidiaries in 10 other European countries, on the 50% capital entry by Mid Europa Partners, one of the leading private equity funds in
17 August 2012
http://www.allenovery.com/news/en-gb/articles/Pages/Walmark-Mid Europa.aspx
China has a complicated and unique tendering system for drugs – and patents play an important role in almost every tender.
14 March 2017
http://www.allenovery.com/publications/en-g … nts-in-Chinese-pharmaceutical-tendering.aspx
This article was written by Geert Glas and Dieter Delarue of our Belgian Life Sciences practice.
12 September 2012
http://www.allenovery.com/publications/en-g … s/Pharmaceutical-Advertising-in-Belgium.aspx


  • Add comment (optional)